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Sir
McKinney et al (1998) (Br J Cancer 78: 974–979) recently
reported their 22-year regional series of 455 cases of childhood
central nervous system (CNS) tumours, in which they demon-
strated a consistently increasing annual incidence and an apparent
shift in the age distribution of astrocytomas. Geographical analysis
revealed a definite distribution pattern at county level, implying a
link with large-scale environmental factors, although no definite
associations were found with socioeconomic group, ethnicity or
population density.
They commented on the paucity of similar reports on the
descriptive epidemiology of childhood CNS tumours, but omitted
to refer to the study from the West Midlands (Stevens et al, 1991).
The West Midlands Regional Children’s Tumour Research Group
(WMRCTRG) is also a specialist childhood cancer registry,
holding population-based data from 1957 onwards on all children
resident or treated in the West Midlands, one of the largest Health
Authorities in England and Wales. Routine histopathological
review has been carried out on over 2000 cases of solid tumour
(Parkes et al, 1997), including over 80% of the CNS tumours in the
Register.
In our 1980–1984 study of 147 brain tumours (Stevens et al,
1991), we reported an incidence of 26.5 per million children per
year, which compares with the 28 in McKinney’s study. We have
subsequently analysed a further 17 years’ worth of data
(1975–1996), a total of 697 cases, which demonstrate an overall
age-standardized incidence rate for the series of 29.8. As reported
in Yorkshire, we have also seen a small significant (P = 0.04)
increase in the incidence of all CNS tumour types over the 22-year
period from 24 to 29.7 per million per year. However, we observed
a large increase in the incidence of astrocytoma over the period
(P = 0.002), the only one of the five subtypes to show a significant
increase in the West Midlands. Interestingly, we also demonstrated
a significant increase in the 0–4-year age-group (P = 0.0004). This
supports the age distribution shift reported by McKinney et al,
which may reflect improving diagnostic services over time.
McKinney et al also reported a statistically significant increase
in the incidence of PNET/medulloblastoma, which agrees with
findings in the North Western region, but conflicts with those of
Thorne and colleagues (Thorne et al, 1994) who found a statisti-
cally significant decline in these tumours in the Southwest region
of England. We have previously analysed the incidence in the West
Midlands over a similar period (Morland and Parkes, 1995) and
demonstrated a non-significant decrease, as was also found in the
northern region. The existence of these five regional variations is
interesting, although the reason for the differences is as yet
unclear.
Geographical analysis has been performed on a subset of the
West Midlands data (unpublished report), which suggested that
there might be higher rates in the rural areas of the region, but
owing to small numbers, this cannot be stated with certainty. It is
intended to extend the analysis to a longer time period, which may
reveal further evidence.
In summary, it is difficult to explain the contrasting findings and
wide variations in incidence of particular subtypes between the
regions, which may be accounted for by geographical and environ-
mental influences. It would therefore be interesting to investigate
the situation on a national basis with data from all regions, in order
to plot the larger topographical picture, which would enable
further aetiological hypotheses.
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